Mediwound (MDWD) has released an update.
MediWound Ltd., an Israeli biopharmaceutical company, has entered into a Share Purchase Agreement with undisclosed purchasers to issue and sell company securities, subject to terms and conditions and certain exemptions from registration requirements. The agreement outlines the mutual covenants, definitions, purchase price per share, and the obligations of both parties, and it occurs within a specific timeline following the execution of all necessary documents.
For further insights into MDWD stock, check out TipRanks’ Stock Analysis page.
